Wednesday April 1, 2020

Dundalk’s Diaceutics set for global expansion

8th April, 2018
Andrew Gowdy, WhiteRock Capital Partners; Peter Keeling, Diaceutics; and Clive Lennox, Silicon Valley Bank

Company: Diaceutics

Done Deal:€4.3m funding

The clincher:“Diaceutics is paving the way when it comes to precision medicine, transforming how patients are diagnosed and treated” – Andrew Gowdy, senior portfolio manager, Whiterock Capital Partners

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

What’s coming up today and what you might have missed

Hannah O’Brien | 3 months ago

What’s coming up today and what you might have missed.

Hannah O’Brien | 3 months ago